JA Fishman, RH Rubin - The New England journal of medicine, 1998 - nejm.highwire.org A primary goal in organ transplantation is the prevention or effective treatment
of infection, the most common life-threatening complication of long-term
immunosuppressive therapy. The challenges involved in achieving this goal ... Cited by 969 - Related articles - BL Direct - All 6 versions
BL Kasiske, CB Cangro, S Hariharan, DE … - American Journal of Transplantation Supplement, 2001 - pt.wkhealth.com These guidelines are designed to facilitate the evaluation of candidates for
renal transplantation. Although they are meant to be comprehensive, they cannot
cover every possible aspect of the evaluation. Each renal transplant ... Cited by 353 - Related articles - BL Direct - All 3 versions
CS Crumpacker - The New England Journal of Medicine, 1996 - nejm.highwire.org Ganciclovir is a nucleoside analogue of guanosine, a homologue of acyclovir, and
the first antiviral drug to be effective in the treatment of cytomegalovirus
(CMV) disease in humans. 1 , 2 , 3 , 4 It inhibits not only all the ... Cited by 256 - Related articles - All 4 versions
R Patel, DR Snydman, RH Rubin, M Ho, M … - Transplantation, 1996 - journals.lww.com Skip Navigation Links Home > May 15, 1996 - Volume 61 - Issue 9 >
Cytomegalovirus Prophylaxis in Solid Organ Transplant Recipi... ... Patel,
Robin; Snydman, David R.; Rubin, Robert H.; Ho, Monto; Pescovitz, Mark; ... Cited by 162 - Related articles - BL Direct - All 4 versions
- ►nih.gov IG Sia, R Patel - Clinical Microbiology Reviews, 2000 - cmr.highwire.org In the past three decades since the inception of human organ transplantation,
cytomegalovirus (CMV) has gained increasing clinical import because it is a
common pathogen in the immunocompromised transplant recipient. Patients may ... Cited by 163 - Related articles - BL Direct - All 6 versions
- ►annals.org [PDF] AC Kalil, J Levitsky, E Lyden, J Stoner, AG … - Annals of internal medicine, 2005 - Am Coll Physicians Background: Cytomegalovirus (CMV), the most common op- portunistic viral
infection in solid organ transplant recipients, is associated with substantial
morbidity and mortality. Purpose: To assess the efficacy of universal ... Cited by 132 - Related articles - BL Direct - All 4 versions
IA Darenkov, MA Marcarelli, GP Basadonna, … - Transplantation, 1997 - journals.lww.com Darenkov, Ivan A.; Marcarelli, Margaret A.; Basadonna, Giacomo P.; Friedman, Amy
L.; Lorber, Kathleen M.; Howe, John G.; Crouch, Jill; Bia, Margaret J.; Kliger,
Alan S.; Lorber, Marc I. ... 2 Section of Organ Transplantation, ... Cited by 128 - Related articles - BL Direct - All 3 versions
- ►otxchina.com [PDF] EM Hodson, CA Jones, AC Webster, GFM … - The Lancet, 2005 - Elsevier Compared with placebo or no treatment, prophylaxis with aciclovir, ganciclovir,
or valaciclovir significantly reduced the risks of cytomegalovirus disease (19
trials, 1981 patients; relative risk 0·42 [95% CI 0·34–0·52]), ... Cited by 117 - Related articles - All 11 versions
